Myxoma of the Nerve Sheath

Types

Types of Myxoma of the Nerve Sheath:

1. Intraneural Myxoma: Intraneural myxoma refers to the formation of myxomatous tissue within the nerve itself. This type of myxoma typically affects peripheral nerves, causing localized? swelling?, pain?, and sensory abnormalities. Prompt diagnosis? is crucial to prevent further nerve damage.
2. Extraneural Myxoma: Extraneural myxoma refers to the growth of myxomatous tissue around the nerve sheath rather than within the nerve. This type often affects larger nerves and may result in compressive symptoms such as weakness?, numbness?, and tingling in the affected area.

Causes

While the exact causes of myxoma formation are not fully understood, various factors have been identified that may contribute to its development.

1. Genetic Factors: Certain genetic mutations and abnormalities, such as neurofibromatosis type 1 (NF1) and the Carney complex, have been associated with an increased risk of myxoma formation within the nerve sheath.
2. Hereditary Syndromes: Rare hereditary syndromes like schwannomatosis and multiple endocrine neoplasia type 2B (MEN2B) have been linked to the development of myxomas in peripheral nerves.
3. Trauma: Nerve injuries or trauma, including surgical procedures or accidents, may trigger the formation of myxomas within the nerve sheath.
4. infection?, or irritation, often causing pain?, swelling?, heat, or redness. সহজ বাংলা: শরীরের প্রদাহ; ব্যথা, ফোলা বা লালভাব হতে পারে।" data-rx-term="inflammation" data-rx-definition="Inflammation is the body’s response to injury, infection, or irritation, often causing pain, swelling, heat, or redness. সহজ বাংলা: শরীরের প্রদাহ; ব্যথা, ফোলা বা লালভাব হতে পারে।">Inflammation?: Chronic? inflammation caused by conditions such as chronic infections, autoimmune? disorders, or chronic nerve irritation, may contribute to the development of myxoma.
5. Hormonal Imbalances: Hormonal imbalances, particularly excess growth hormone or estrogen, have been suggested as potential causes of myxoma of the nerve sheath.
6. Radiation Exposure: Previous exposure to ionizing radiation, such as radiation therapy for cancer treatment, may increase the risk of myxoma formation in peripheral nerves.
7. Chemical Exposure: Exposure to certain chemicals, toxins, or environmental pollutants, such as vinyl chloride, may play a role in the development of myxoma within the nerve sheath.
8. Age: While myxoma of the nerve sheath can occur at any age, it is more commonly observed in adults, particularly those over 40 years old.
9. Gender: There is a slight predilection for myxoma of the nerve sheath in females, although it can affect both males and females.
10. Hormonal Changes: Fluctuations in hormone levels during puberty, pregnancy, or menopause may influence the development of myxomas within the nerve sheath.
11. Chronic? Nerve Compression: Prolonged compression of peripheral nerves, such as in carpal tunnel syndrome or spinal stenosis?, may contribute to myxoma formation.
12. Infection?: Certain viral? or bacterial? infections, such as human papillomavirus (HPV) or Lyme disease, have been suggested as potential triggers for myxoma development.
13. Metabolic Disorders: Underlying metabolic disorders, including insulin? is low or not working well. সহজ বাংলা: রক্তে চিনি বেশি থাকার রোগ।" data-rx-term="diabetes" data-rx-definition="Diabetes is a condition where blood sugar stays too high because insulin is low or not working well. সহজ বাংলা: রক্তে চিনি বেশি থাকার রোগ।">diabetes? or hyperlipidemia, may contribute to the formation of myxomas within the nerve sheath.
14. Neurofibromas: Presence of pre-existing neurofibromas, benign? tumors originating from nerve tissue, may increase the risk of myxoma formation.
15. Immune System Disorders: Autoimmune? disorders or compromised immune system function may play a role in the development of myxoma of the nerve sheath.
16. Neurological Conditions: Certain neurological conditions, such as neurofibromatosis type 2 (NF2), have been associated with an increased incidence of myxomas in peripheral nerves.
17. Vascular Abnormalities: Abnormalities in blood vessel formation or function, such as arteriovenous malformations, may contribute to the development of myxoma within the nerve sheath.
18. Connective Tissue Disorders: Inherited connective tissue disorders, including Marfan syndrome or Ehlers-Danlos syndrome, have been linked to an increased risk of myxoma formation.
19. Chronic? infection?, or irritation, often causing pain?, swelling?, heat, or redness. সহজ বাংলা: শরীরের প্রদাহ; ব্যথা, ফোলা বা লালভাব হতে পারে।" data-rx-term="inflammation" data-rx-definition="Inflammation is the body’s response to injury, infection, or irritation, often causing pain, swelling, heat, or redness. সহজ বাংলা: শরীরের প্রদাহ; ব্যথা, ফোলা বা লালভাব হতে পারে।">Inflammation?: Persistent inflammation due to conditions like chronic nerve compression or repetitive trauma may contribute to myxoma development.
20. Lifestyle Factors: Unhealthy lifestyle habits, such as smoking, excessive alcohol consumption, or a sedentary lifestyle, may increase the risk of myxoma formation.
21. Medications: Certain medications, such as tamoxifen used in breast cancer treatment, have been implicated in the development of myxomas.
22. Occupational Hazards: Occupational exposure to certain chemicals or physical hazards may contribute to myxoma formation in the nerve sheath.
23. Family History: Having a family history of myxoma or other related conditions may predispose individuals to developing myxoma of the nerve sheath.
24. Chronic Systemic? Diseases: Chronic systemic diseases, such as swelling?, stiffness?, or reduced movement. সহজ বাংলা: জয়েন্টের প্রদাহ।" data-rx-term="arthritis" data-rx-definition="Arthritis means joint inflammation causing pain, swelling, stiffness, or reduced movement. সহজ বাংলা: জয়েন্টের প্রদাহ।">arthritis?: Rheumatoid arthritis is an autoimmune? joint disease causing infection?, or irritation, often causing pain, swelling, heat, or redness. সহজ বাংলা: শরীরের প্রদাহ; ব্যথা, ফোলা বা লালভাব হতে পারে।" data-rx-term="inflammation" data-rx-definition="Inflammation is the body’s response to injury, infection, or irritation, often causing pain, swelling, heat, or redness. সহজ বাংলা: শরীরের প্রদাহ; ব্যথা, ফোলা বা লালভাব হতে পারে।">inflammation?, pain, and swelling. সহজ বাংলা: রোগপ্রতিরোধ ব্যবস্থার ভুল আক্রমণে জয়েন্টের প্রদাহ।" data-rx-term="rheumatoid arthritis" data-rx-definition="Rheumatoid arthritis is an autoimmune joint disease causing inflammation, pain, and swelling. সহজ বাংলা: রোগপ্রতিরোধ ব্যবস্থার ভুল আক্রমণে জয়েন্টের প্রদাহ।">rheumatoid arthritis? or systemic lupus erythematosus, may be associated with an increased risk of myxoma formation.
25. Nerve Sheath Abnormalities: Structural abnormalities or malformations of the nerve sheath may contribute to the development of myxoma.
26. Abnormal Cell Growth: Dysregulation of cellular growth processes, leading to abnormal cell proliferation, may result in myxoma formation within the nerve sheath.
27. Unknown Factors: In some cases, myxoma of the nerve sheath may develop without any identifiable cause, suggesting the involvement of unknown factors.
28. Research Studies: Ongoing scientific research aims to uncover additional causes and risk factors associated with myxoma formation within the nerve sheath.
29. Early Detection: Prompt diagnosis and early detection of myxoma can aid in understanding its causes and implementing appropriate treatment strategies.
30. Multidisciplinary Approach: Collaboration between various healthcare specialties, including neurology, oncology, and genetics, is crucial in comprehensively addressing the myxoma of the nerve sheath.

Symptoms

Symptoms of Myxoma of the Nerve Sheath:

1. Numbness or Tingling Sensation: Numbness or tingling sensations may occur in the affected area due to nerve compression or irritation caused by the myxoma.
2. Pain: Localized or radiating pain can be a symptom of myxoma of the nerve sheath. The intensity of pain may vary from mild to severe.
3. Muscle Weakness: Affected muscles may become weak, leading to difficulties in performing regular activities.
4. Loss of Sensation: The tumor can interfere with nerve signals, resulting in a loss of sensation in the region supplied by the affected nerve.
5. Swelling: Swelling around the site of the tumor can occur due to inflammation or accumulation of fluid.
6. Limited Range of Motion: Myxoma of the nerve sheath may restrict the movement of the affected body part, causing a limited range of motion.
7. Muscle Wasting: In some cases, the muscles connected to the affected nerve may start to waste away, leading to muscle atrophy.
8. Changes in Skin Texture: The skin over the affected area may become rough, discolored, or develop an abnormal texture.
9. Muscle Spasms: Uncontrollable muscle contractions or spasms may occur as a result of nerve irritation caused by the tumor.
10. Sensitivity to Touch: Increased sensitivity to touch or heightened response to stimuli may be experienced in the area surrounding the tumor.
11. Abnormal Reflexes: Myxoma of the nerve sheath can cause abnormal reflexes in the affected region.
12. Difficulty with Fine Motor Skills: The tumor’s impact on nerves can lead to difficulties in performing precise movements, affecting fine motor skills.
13. Unexplained Fatigue: Feelings of tiredness or exhaustion without an apparent cause may be associated with myxoma of the nerve sheath.
14. Altered Temperature Sensitivity: Changes in the ability to perceive hot or cold temperatures in the affected area can occur due to nerve involvement.
15. Bowel or Bladder Dysfunction: Rarely, myxoma of the nerve sheath may result in bowel or bladder dysfunction, causing issues with urination or defecation.
16. Balance Problems: Nerve compression or damage from the tumor can disrupt the balance, leading to coordination difficulties.
17. Difficulty Swallowing: In cases where the tumor affects nerves involved in swallowing, difficulties or discomfort while swallowing may arise.
18. Speech Impairment: If the tumor affects nerves related to speech and language, speech impairments may manifest.
19. Visual or Hearing Changes: Depending on the location of the tumor, visual or hearing changes may be observed in some individuals.
20. Facial Weakness: Myxoma of the nerve sheath near facial nerves may cause weakness or paralysis on one side of the face.

Diagnosis

Prompt diagnosis plays a crucial role in effective treatment and management of this condition.

1. Clinical History and Physical Examination: A comprehensive clinical history and physical examination can provide valuable insights into the patient’s symptoms, medical history, and any noticeable physical abnormalities that might be associated with myxoma of the nerve sheath.
2. Neurological Examination: A detailed neurological examination helps assess the patient’s reflexes, muscle strength, sensation, and coordination. Any abnormalities detected during this examination may indicate the presence of myxoma.
3. Magnetic Resonance Imaging (MRI): MRI scans use powerful magnets and radio waves to create detailed images of the affected area. This non-invasive test can help visualize the location, size, and characteristics of myxoma tumors, enabling accurate diagnosis.
4. Computed Tomography (CT) Scan: CT scans use X-rays to generate cross-sectional images of the body. This diagnostic tool helps identify abnormal tissue growth and can be particularly useful in detecting myxoma tumors within the nerve sheath.
5. Ultrasound: Ultrasound imaging uses high-frequency sound waves to create real-time images of internal structures. It can assist in evaluating the presence and characteristics of myxoma tumors.
6. Nerve Conduction Studies (NCS): NCS measures the speed and strength of electrical signals as they travel along the nerves. This test helps evaluate the integrity of the affected nerves and may indicate abnormalities associated with myxoma of the nerve sheath.
7. Electromyography (EMG): EMG involves the insertion of fine needles into muscles to assess their electrical activity. This test can help identify muscle dysfunction or nerve damage caused by myxoma tumors.
8. Biopsy: A biopsy involves the surgical removal of a small tissue sample for laboratory analysis. It is a definitive diagnostic method to confirm the presence of myxoma of the nerve sheath and determine its specific characteristics.
9. Histopathological Analysis: Histopathological analysis examines the tissue sample obtained from a biopsy under a microscope. It helps identify the cellular structure and components of the tumor, aiding in accurate diagnosis.
10. Immunohistochemistry: Immunohistochemistry involves staining tissue samples with specific antibodies to detect specific proteins or markers associated with myxoma of the nerve sheath. This technique can provide additional information about the tumor’s origin and nature.
11. Genetic Testing: Genetic testing can identify mutations or genetic abnormalities associated with myxoma tumors. These tests may help determine the hereditary factors contributing to the development of the condition.
12. Blood Tests: Blood tests can evaluate various factors such as complete blood count, electrolyte levels, and tumor markers. While not specific to myxoma, abnormal results may indicate the presence of the tumor or its effects on the body.
13. Fine Needle Aspiration (FNA): FNA involves using a thin needle to withdraw a sample of fluid or cells from the tumor for analysis. This minimally invasive procedure may aid in the diagnosis of myxoma of the nerve sheath.
14. Immunocytochemistry: Immunocytochemistry uses antibodies to detect specific proteins or markers in the cells obtained through FNA. This technique helps confirm the presence of myxoma and provides additional diagnostic information.
15. Molecular Testing: Molecular testing examines genetic material from the tumor cells to identify specific mutations or alterations associated with myxoma. It can aid in determining appropriate treatment options and prognosis.
16. Lumbar Puncture: Lumbar puncture involves collecting cerebrospinal fluid (CSF) through a needle inserted into the lower back. While not specific to myxoma, analyzing CSF may help detect any abnormal cells or markers associated with the tumor.
17. X-ray: X-rays provide a basic imaging technique that can help detect bone abnormalities or skeletal changes caused by myxoma of the nerve sheath. However, they are less effective in visualizing soft tissue structures.
18. Positron Emission Tomography (PET) Scan: PET scans use radioactive tracers to detect metabolic activity in the body. While not commonly used for myxoma, PET scans can be helpful in identifying potential metastasis or evaluating treatment response.
19. Magnetic Resonance Neurography (MRN): MRN is a specialized MRI technique that focuses on imaging nerves and their surrounding structures. It can provide detailed information about the involvement and extent of myxoma tumors within the nerve sheath.
20. Nerve Biopsy: In some cases, a nerve biopsy may be performed to obtain a tissue sample directly from the affected nerve. This procedure can aid in confirming the diagnosis of myxoma of the nerve sheath and assessing the nerve’s condition.
21. Electroencephalogram (EEG): EEG measures electrical activity in the brain and can be used to evaluate any abnormalities associated with myxoma that affect brain function or cause seizures.
22. Genetic Counseling: Genetic counseling involves assessing an individual’s risk of developing myxoma of the nerve sheath based on family history and genetic testing results. This can help guide decisions regarding further screening or preventive measures.
23. Neuroimaging with Contrast: Administering contrast agents during MRI or CT scans can enhance the visibility of tumors and aid in the accurate identification of myxoma within the nerve sheath.
24. Nerve Excision and Biopsy: In cases where myxoma is suspected but not conclusively diagnosed through other methods, surgical excision of the affected nerve followed by biopsy can provide definitive confirmation.
25. Dermatological Examination: A dermatological examination can help identify any skin changes or abnormalities that may be associated with myxoma of the nerve sheath.
26. Ophthalmological Examination: Ophthalmological examinations assess the eyes for any signs of myxoma-associated abnormalities such as optic nerve involvement or changes in visual acuity.
27. Audiological Examination: Audiological examinations evaluate hearing function and can help detect any auditory abnormalities caused by myxoma of the nerve sheath.
28. Spinal Tap: A spinal tap, or lumbar puncture, can help analyze the cerebrospinal fluid for the presence of abnormal cells or markers associated with myxoma.
29. Molecular Profiling: Molecular profiling techniques analyze the genetic makeup of myxoma tumors to identify specific mutations or alterations that can guide targeted treatment strategies.
30. Clinical Consultation: Seeking consultation from healthcare professionals with expertise in neurology, oncology, and related specialties can provide valuable insights and guidance in diagnosing myxoma of the nerve sheath.

Treatment

If you or someone you know is diagnosed with myxoma of the nerve sheath, understanding the available treatment options is crucial.

1. Surgery: Surgery is often the primary treatment for myxoma of the nerve sheath. It involves the removal of the tumor and affected nerve tissues. This procedure aims to eliminate the tumor completely and prevent its recurrence.
2. Radiation Therapy: Radiation therapy uses high-energy X-rays to target and destroy cancer cells. It can be employed as a primary treatment or in combination with surgery to ensure thorough tumor eradication.
3. Chemotherapy: Chemotherapy utilizes drugs to kill cancer cells throughout the body. While it may not be the main treatment for myxoma of the nerve sheath, it can be effective in cases where the tumor has spread to other areas.
4. Targeted Therapy: Targeted therapy involves the use of drugs that specifically target cancer cells, minimizing damage to healthy cells. It can help block the growth and spread of myxoma tumors.
5. Immunotherapy: Immunotherapy harnesses the body’s immune system to fight against cancer cells. It can enhance the immune response and improve the body’s ability to combat myxoma of the nerve sheath.
6. Cryosurgery: Cryosurgery is a technique that employs extreme cold to freeze and destroy cancer cells. It can be a useful treatment option for small myxoma tumors located in accessible areas.
7. Radiofrequency Ablation: Radiofrequency ablation uses high-frequency electrical currents to heat and destroy cancer cells. This minimally invasive procedure can be beneficial for tumors that are not easily accessible by surgery.
8. Laser Surgery: Laser surgery utilizes focused laser beams to remove or destroy cancer cells. It is a precise treatment option that can be effective for certain cases of myxoma of the nerve sheath.
9. Mohs Micrographic Surgery: Mohs surgery involves the removal of layers of cancerous tissue until only healthy tissue remains. This technique is particularly suitable for tumors located on the face or delicate areas.
10. Intrathecal Chemotherapy: Intrathecal chemotherapy delivers anticancer drugs directly into the cerebrospinal fluid surrounding the brain and spinal cord. It is effective in treating myxoma tumors in these areas.
11. Electrodessication and Curettage: Electrodessication and curettage involve the scraping and burning of cancerous tissue. This method can be used for superficial myxoma tumors and offers a high success rate.
12. Intralesional Therapy: Intralesional therapy involves injecting medication directly into the tumor. This targeted treatment can be effective in reducing the size of myxoma tumors.
13. Biological Therapy: Biological therapy utilizes substances that stimulate the body’s natural defenses against cancer. It can help modulate the immune response and inhibit myxoma tumor growth.
14. Photodynamic Therapy: Photodynamic therapy combines light and a photosensitizing agent to destroy cancer cells. It can be useful for myxoma tumors located near the surface of the skin.
15. Stereotactic Radiosurgery: Stereotactic radiosurgery uses precisely targeted radiation beams to treat small myxoma tumors. It is a non-invasive procedure that can be performed in a single session.
16. High-Intensity Focused Ultrasound (HIFU): HIFU therapy utilizes focused ultrasound waves to heat and destroy cancer cells. It can be an alternative treatment for myxoma tumors that are not easily accessible by surgery.
17. Angiogenesis Inhibitors: Angiogenesis inhibitors block the formation of new blood vessels, inhibiting the tumor’s blood supply. This treatment can help slow down myxoma tumor growth.
18. Cryoablation: Cryoablation involves freezing cancer cells to destroy them. It can be an effective treatment option for small myxoma tumors located close to the skin’s surface.
19. Hormone Therapy: Hormone therapy can be used to slow down or prevent the growth of hormone-sensitive myxoma tumors. It alters hormone levels in the body to impede tumor development.
20. Percutaneous Ethanol Injection: Percutaneous ethanol injection involves injecting ethanol directly into the tumor to destroy cancer cells. It can be an effective treatment for small myxoma tumors.
21. Nonsteroidal Anti-inflammatory Drugs (NSAIDs): NSAIDs can help alleviate pain and reduce inflammation associated with myxoma of the nerve sheath. They offer symptomatic relief but do not directly target the tumor.
22. Pain Management Techniques: Various pain management techniques, such as medication, physical therapy, and acupuncture, can provide relief from myxoma-related pain and discomfort.
23. Supportive Care: Supportive care focuses on improving the patient’s overall well-being and quality of life. It involves managing symptoms, providing psychological support, and enhancing overall comfort.
24. Palliative Care: Palliative care aims to improve the quality of life for patients with advanced myxoma of the nerve sheath. It focuses on symptom management and providing emotional support for both the patient and their loved ones.
25. Clinical Trials: Clinical trials offer access to innovative treatments that are still under investigation. Participation in clinical trials can provide potential therapeutic options for myxoma of the nerve sheath.
26. Second Opinion: Seeking a second opinion from another healthcare professional specializing in myxoma of the nerve sheath can provide additional insights and treatment options.
27. Genetic Counseling: Genetic counseling can be beneficial for individuals with a family history of myxoma tumors. It helps assess the risk factors and provides guidance on potential preventive measures.
28. Regular Monitoring and Follow-up: Regular monitoring and follow-up appointments with your healthcare provider are essential to track the progress of the disease, evaluate treatment effectiveness, and address any emerging concerns.
29. Lifestyle Modifications: Adopting a healthy lifestyle, including regular exercise, a balanced diet, and stress management, can contribute to overall well-being and potentially enhance treatment outcomes.
30. Patient Support Groups: Engaging with patient support groups or online communities can provide emotional support, share experiences, and offer valuable information and resources.

Medications

Drugs that have shown promise in the treatment of myxoma of the nerve sheath.

1. Vincristine: Vincristine is a chemotherapy drug that has demonstrated effectiveness in treating myxoma of the nerve sheath. It works by disrupting the tumor’s cell division, ultimately leading to its regression.
2. Methotrexate: Methotrexate is another chemotherapy medication that inhibits the growth of cancer cells. It is often used in combination with other drugs to enhance its therapeutic effects.
3. Doxorubicin: Doxorubicin is a powerful anthracycline antibiotic with potent antitumor activity. It works by intercalating with DNA and inhibiting its replication, thereby impeding tumor growth.
4. Cisplatin: Cisplatin is a platinum-based chemotherapy drug that hinders cell division by forming crosslinks within DNA strands. It is commonly administered in combination with other medications to augment treatment outcomes.
5. Paclitaxel: Paclitaxel is a taxane drug that promotes microtubule stabilization, disrupting the normal cell division process in the tumor. It has demonstrated efficacy in myxoma of the nerve sheath treatment.
6. Gemcitabine: Gemcitabine is a nucleoside analogue that inhibits DNA synthesis, thereby preventing the proliferation of cancer cells. It is often used in combination with other drugs to enhance therapeutic responses.
7. Etoposide: Etoposide is a topoisomerase II inhibitor that disrupts DNA replication and repair in tumor cells. It is frequently employed in combination regimens for myxoma of the nerve sheath treatment.
8. Ifosfamide: Ifosfamide is an alkylating agent that damages the DNA of cancer cells, hindering their ability to divide and grow. It is often used in combination with other drugs to maximize treatment efficacy.
9. Bevacizumab: Bevacizumab is a monoclonal antibody that targets vascular endothelial growth factor (VEGF), impeding the tumor’s blood supply. By starving the tumor, its growth and spread can be restrained.
10. Imatinib: Imatinib is a tyrosine kinase inhibitor that targets specific signaling pathways involved in tumor growth. It has shown promise in treating certain types of myxoma of the nerve sheath.
11. Sorafenib: Sorafenib is a multikinase inhibitor that disrupts the signaling pathways necessary for tumor growth and angiogenesis. It is administered orally and has demonstrated efficacy in myxoma of the nerve sheath treatment.
12. Everolimus: Everolimus is an mTOR inhibitor that interferes with the signaling pathways involved in cell growth and division. It has shown potential in the treatment of myxoma of the nerve sheath.
13. Trabectedin: Trabectedin is a marine-derived compound that has antitumor effects by interfering with DNA repair mechanisms. It is often used in refractory cases of myxoma of the nerve sheath.
14. Nilotinib: Nilotinib is a tyrosine kinase inhibitor that targets specific abnormal proteins involved in tumor growth. It has shown promise in the treatment of myxoma of the nerve sheath.
15. Dasatinib: Dasatinib is another tyrosine kinase inhibitor that hampers the activity of specific proteins responsible for tumor growth. It is administered orally and has demonstrated efficacy in certain cases.
16. Regorafenib: Regorafenib is a multikinase inhibitor that targets various pathways implicated in tumor progression. It has shown promise in the treatment of myxoma of the nerve sheath.
17. Pazopanib: Pazopanib is a tyrosine kinase inhibitor that blocks the activity of certain proteins involved in angiogenesis and tumor growth. It is administered orally and has demonstrated efficacy in certain cases.
18. Sunitinib: Sunitinib is a multitargeted tyrosine kinase inhibitor that impairs the growth of blood vessels within tumors. It has shown potential in the treatment of myxoma of the nerve sheath.
19. Temsirolimus: Temsirolimus is an mTOR inhibitor that interferes with the signaling pathways involved in cell growth and division. It has shown promise in certain cases of myxoma of the nerve sheath.
20. Axitinib: Axitinib is a tyrosine kinase inhibitor that targets specific proteins involved in tumor angiogenesis. It is administered orally and has demonstrated efficacy in certain cases.